USPTO serial 50141198
BRISC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with BRISC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brent D. Sokol
Brent D. Sokol Greenberg Traurig, LLP1840 Century Park East, Suite 1900Los Angeles, CA 90067United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of infectious diseases, cancer, metabolic diseases, renal diseases, gout and anemia, cardiovascular disorders, age related diseases, autoimmune system disorders, diabetes, central nervous system disorders, heart and blood disorders, pain, inflammation, sepsis, alopecia, skin, obesity and cognitive disorders; Biopharmaceutical preparations for the treatment of infectious diseases, cancer, metabolic diseases, renal diseases, gout and anemia, cardiovascular disorders, age related diseases, autoimmune system disorders, diabetes, central nervous system disorders, heart and blood disorders, pain, inflammation, sepsis, alopecia, skin, obesity and cognitive disorders | ACTIVE | — |
| 040 | Custom biomanufacturing of pharmaceuticals | ACTIVE | — |
| 042 | Research and development in the field of pharmaceuticals; Research and development in the field of life sciences; Research and development in the field of genetics; Research and development in the field of biotechnology; Pharmaceutical research services; Consulting services in the field of pharmaceutical research and development; Laboratory services for biomanufacturing viral vectors for pharmaceutical use; Pharmaceutical research and development; Providing scientific research information in the field of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Development of pharmaceutical preparations and medicines; Research and development of siRNA drugs | ACTIVE | — |
| 044 | Pharmaceutical advice; Providing medical information in the field of siRNA therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 1, 2026 | NWAP | NEW APPLICATION ENTERED | — |